Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01864512
Recruitment Status : Withdrawn (No eligible patient was enrolled.)
First Posted : May 29, 2013
Last Update Posted : April 20, 2016
Chinese Academy of Medical Sciences
Information provided by (Responsible Party):
Ming Hou, Shandong University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : March 2014
Estimated Study Completion Date : April 2014